Table 1 Analysis of associations between patient clinicopathological features and Higd-1a expression.
From: The potential antitumor mechanism and clinical potential of Higd-1a in colorectal cancer
Pathological features | n | Low Higd-1a level (n) | High Higd-1a level (n) | χ2 | P |
|---|---|---|---|---|---|
Gender | |||||
Female | 65 | 35 | 30 | 0.003 | 0.954 |
Male | 60 | 32 | 28 | ||
Age | |||||
<65 years old | 77 | 42 | 35 | 0.072 | 0.954 |
≥65 years old | 48 | 35 | 23 | ||
Depth of tumor invasion | |||||
T2–T3 | 71 | 36 | 35 | 0.554 | 0.457 |
T4 | 54 | 31 | 23 | ||
Lymph node metastasis | |||||
No | 101 | 53 | 48 | 0.268 | 0.605 |
Yes | 24 | 14 | 10 | ||
Nerve invasion | |||||
No | 100 | 56 | 44 | 1.158 | 0.282 |
Yes | 25 | 11 | 14 | ||
Vascular cancer embolus | |||||
No | 101 | 54 | 47 | 0.004 | 0.951 |
Yes | 24 | 11 | 14 | ||
TNM staging | |||||
I–II | 53 | 20 | 33 | 9.311 | 0.002 |
III–IV | 72 | 41 | 25 | ||
